Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Anticuerpo monoclonal CCR5 para el tratamiento de personas con infección por VIH

Esta versión no es la más reciente

ver la versión actual 26 julio 2014

Información

DOI:
https://doi.org/10.1002/14651858.CD008439.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 08 diciembre 2010see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de VIH/SIDA

Copyright:
  1. Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Lun Li

    Evidence‐Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou City, China

  • TianTian Sun

    Shanghai Institute of Digestive Disease, Shanghai Jiao‐Tong University School of Medicine Renji Hospital, Shanghai, China

  • KeHu Yang

    Correspondencia a: Evidence‐Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou City, China

    [email protected]

    [email protected]

  • Peng Zhang

    Evidence‐Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou City, China

  • Wen Qin Jia

    Evidence‐Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou City, China

Contributions of authors

Draft the protocol

Lun Li; TianTian Sun   

Develop and run the search strategy

KeHu Yang

Obtain copies of studies

TianTian Sun    

Select which studies to include (2 people)

Lun Li; Peng Zhang

Extract data from studies (2 people)

 P Zhang; WQ Jia;

Enter data into RevMan

 Lun Li; WenQin Jia 

Carry out the analysis

KeHu Yang; Lun Li  

Interpret the analysis

 KeHu Yang; Peng Zhang

Draft the final review

 Lun Li; KeHu Yang

Update the review

 Lun Li; KeHu Yang 

Declarations of interest

None known

Acknowledgements

The review authors would like to thank the following people (in addition to the peer referees) for commenting on the draft protocol and full text: Angela Broad, Tara Horvath, JinHui Tian, ShaoLiang Sun.

Version history

Published

Title

Stage

Authors

Version

2014 Jul 26

Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection

Review

Lun Li, Jin Hui Tian, KeHu Yang, Peng Zhang, Wen Qin Jia

https://doi.org/10.1002/14651858.CD008439.pub3

2010 Dec 08

Monoclonal CCR5 antibody for treatment of people with HIV infection

Review

Lun Li, TianTian Sun, KeHu Yang, Peng Zhang, Wen Qin Jia

https://doi.org/10.1002/14651858.CD008439.pub2

2010 Mar 17

PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection

Protocol

Lun Li, KeHu Yang, KeHu Yang, TianTian Sun, Peng Zhang, Wen Qin Jia

https://doi.org/10.1002/14651858.CD008439

Differences between protocol and review

None

Notes

No

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.